SCF-PCR BRAID™ THERAPEUTIC SYSTEM | Naviquel-7 Program — Anti-Traumatic Gran Mal Seizures (GTCS)

Framework Code: SCF-PFP-N6K7-EPI-GMS-0001

Classification: SCF Product Architecture (API → Reformulation → PCR Braid Integration)

Product Architecture

From Precision APIs to Functional Cure Systems

SCF delivers a multi-layer therapeutic architecture that integrates:

Targeted APIs (Naviquel-7)
Pharmacokinetic-optimized reformulations
SCF-PCR BRAID™ systems (multi-phase seizure control)

Type	Description	Value	Regulatory Path
APIs	Precision-designed molecules targeting Nav1.6 + Kv7	Mechanistic specificity, reduced off-target effects	505(b)(1) / IND
Reformulated APIs	PK/PD optimized delivery systems (oral MR, intranasal rescue)	Improved CNS exposure, rapid onset + stability	505(b)(2)
SCF-PCR BRAID™ Therapies	Multi-layer therapeutic systems integrating FDA-approved drugs + Naviquel-7	Full-cycle seizure control (preventative, curative, restorative)	Combination product pathway

Naviquel-7 — Dual Ion-Channel Precision API

Molecular Design

Selective Nav1.6 inhibition (persistent/resurgent current)
Kv7.2/7.3 activation (M-current stabilization)
State-dependent binding → targets hyperactive neurons

Primary Targets

Target	Function	Outcome
Nav1.6 (SCN8A)	Sodium influx	↓ pathological firing
Kv7.2/7.3 (KCNQ)	Potassium efflux	↑ membrane stability

SCF Value

Precision excitability control
Reduced sedation vs broad ASMs
Foundation layer for PCR Braid integration

PK/PD-Optimized Delivery Systems

Formulation Types

Format	Function	Clinical Role
Modified-release oral	Sustained CNS exposure	Preventative baseline
Intranasal rapid delivery	Fast BBB penetration	Acute seizure rescue
Closed-loop compatible systems	Triggered dosing	Real-time intervention

Active–Excipient Engineering

CNS-targeted lipophilicity tuning
Reduced peak-to-trough variability
Controlled release aligned to seizure cycles

SCF Value

Converts molecular potency → clinical reliability
Enables time-domain precision (pre-ictal vs ictal)
Integrates with EEG-triggered delivery systems

Multi-Phase Therapeutic Architecture

Layer 1 — PREVENTATIVE (Pre-Ictal Stabilization)

Mechanism Stack

Kv7 activation → Ezogabine / XEN1101
Slow Na⁺ stabilization → Lacosamide
Redox stabilization → NAC + CoQ10

Outcome

Increased seizure threshold
Stabilized membrane potential
Suppressed pre-ictal ion drift

Layer 2 — CURATIVE (Ictal Termination)

Mechanism Stack

Fast Na⁺ blockade → Phenytoin
GABA potentiation → Diazepam / Midazolam
Synaptic suppression → Levetiracetam
Ca²⁺ suppression → Ethosuximide / Zonisamide

Outcome

Rapid seizure termination
Collapse of synchronized firing
Prevention of propagation

Layer 3 — RESTORATIVE (Postictal Realignment)

Mechanism Stack

Mitochondrial recovery → CoQ10 + Creatine
Neuroinflammation control → Anakinra
Synaptic reset → Memantine
GABA rebalancing → Valproate

Outcome

Faster cognitive recovery
Reduced neuroinflammation
Prevention of epileptogenesis

SCF-PCR BRAID™ — Synergy Engine

1+1⇒3 Functional Integration

Interaction	Result
Nav1.6 ↓ + Kv7 ↑	Membrane stabilization
Na⁺ ↓ + Ca²⁺ ↓	Seizure collapse
Ion control + Synaptic modulation	Network desynchronization
Metabolic + Ion recovery	Neuro-cognitive restoration

Emergent Effect

Full-cycle seizure control: prevention → interruption → recovery

Integration Diagram — System Flow

Naviquel-7 API
        ↓
PK/PD Reformulation Layer
        ↓
SCF-PCR BRAID™ SYSTEM

[Preventative] → [Curative] → [Restorative]

Ion Control → Network Stabilization → Cognitive Recovery

Clinical Value Proposition

Compared to Standard Anti-Seizure Therapy

Feature	Conventional ASMs	SCF-PCR BRAID™
Mechanism	Single-target	Multi-layer integrated
Timing	Static dosing	Phase-specific
Recovery	Limited	Active restoration
Precision	Low	High (state-dependent)

Regulatory Positioning

Pathway Strategy

Component	Pathway
Naviquel-7 API	IND → NDA (505(b)(1))
Reformulated systems	505(b)(2)
PCR Braid therapy	Combination product

Explore the Platform

View Pipeline Programs
Request Clinical Data Package
Initiate Partnership Discussion

Dedicated to my cousin Phillip and nephew Ryan (extended family)

SCF-PCR BRAID STRATEGY | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS) — NAVIQUEL-7 — RAPID SEIZURE RELIEF + NEURO-COGNITIVE REALIGNMENT

SCF-PCR BRAID — FDA-ALIGNED DRUG MAPPING & SYNERGISTIC AUGMENTATION

SCF-PCR BRAID — FDA & CLINICAL-STAGE DRUG MAPPING (REFINED, MECHANISM-EXACT)

SCF CRO-READY ASSAY PROTOCOLS (WITH EXACT CONDITIONS) | NAVIQUEL-7 PROGRAM — PRECLINICAL VALIDATION PACKAGE

SCF CRO-READY SYNTHESIS ROUTES | TOP NAVIQUEL-7 ANALOGS (NQ-1, NQ-3, NQ-8, NQ-11, NQ-14)

SCF TOP 10 LEAD CANDIDATES — DOCKING & PREDICTED IC₅₀ DOSSIER | NAVIQUEL-7 PROGRAM (SCF-API-N6K7-001)

SCF API DISCOVERY PROFILE | NAVIQUEL-7 — ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

NAVIQUEL-7 — PRECLINICAL DEVELOPMENT PLAN

NAVIQUEL-7 — SCIENTIFIC BRIEF

SCF API DEVELOPMENT PIPELINE DELIVERABLE | Naviquel-7

SCF CONSOLIDATED MoA / MeA CANDIDATE TABLE | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF MULTI-ION SIMULTANEOUS MAPPING ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF CLINICAL TRANSLATION: INTRAOPERATIVE ION MAPPING TOOLS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF NANOSCALE ION FLUX MEASUREMENT TECHNOLOGIES | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF AI-AUGMENTED SURGICAL GUIDANCE SYSTEM | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF TRANSLATION TO CLINICAL INTRAOPERATIVE MAPPING TOOLS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF SINGLE-CELL ELECTRON FLOW MAPPING TECHNOLOGIES | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF ELECTRON FLOW ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF PRECISION NEUROCHEMICAL DELIVERY SYSTEMS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF AUTONOMOUS DRUG DESIGN PLATFORM (ADDP) | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF LARGE-SCALE QUANTUM LIGAND LIBRARY GENERATION PLATFORM (10⁶ COMPOUNDS) | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF DYNAMIC ELECTRON-DENSITY RECONFIGURING MOLECULES (DERMs) | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF GENERATION OF LIGANDS WITH OPTIMAL HOMO/LUMO PROFILES | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF QUANTUM-GUIDED LIGAND ENGINEERING PLATFORM | ELECTRON ORBITAL–DRIVEN MOLECULAR DESIGN FOR ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF QUANTUM-LEVEL MODELING FRAMEWORK | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF ULTRA-HIGH-RESOLUTION CRYO-EM (<2 Å) PLATFORM FOR ION CHANNEL TARGETING | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF CLOSED-LOOP DRUG DELIVERY SYSTEM LINKED TO EEG SIGNALS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF CRYO-EM–GUIDED SUBTYPE-SPECIFIC DRUG DESIGN PLATFORM | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF ION-CHANNEL SUBTYPE–SELECTIVE DRUG DESIGN FRAMEWORK | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF MEMBRANE DYNAMICS ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF MULTI-OMICS–GUIDED ELECTROPHYSIOLOGICAL MODELING FRAMEWORK | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF NEUROCHEMICAL → BIOELECTRICAL DYSFUNCTION ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF SPATIAL MULTI-OMICS INTEGRATION WITH SURGICAL MAPPING | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF INTEGRATION WITH MULTI-OMIC GENE NETWORKS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF NETWORK TOPOLOGY MAPPING ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF MULTI-OMIC GENE NETWORK MODELING OF SEIZURE THRESHOLDS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF CLOSED-LOOP SURGERY + NEUROMODULATION HYBRID SYSTEM | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF SURGICAL PRECISION MAPPING ATLAS | NEUROSURGICAL INTERVENTIONS FOR GRAN MAL SEIZURES (GTCS)

SCF CYTOGENESIS TRACKING WITH PSEUDOTIME TRAJECTORY MAPPING | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF RELATIVISTIC CYTOGENESIS ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF NEURO-AUTONOMIC SHOCK ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF SINGLE-CELL MULTI-OMICS MAPPING ATLAS | EPILEPTOGENIC FOCI (ANTI-TRAUMATIC & GENERALIZED EPILEPTOGENESIS)

SCF PATHOMECHANISM + GENE ACTIVATION + GENE LOCI MAPPING ATLAS | EPILEPTOGENESIS (GENERALIZED — MULTI-ETIOLOGY, INCLUDING TRAUMA-DRIVEN)

SCF PATHOMECHANISM + GENE ACTIVATION + GENE LOCI MAPPING ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (POST-TRAUMATIC EPILEPTOGENESIS → GTCS)

SCF ORIGIN-SPECIFIC BIOMARKER PANELS (ENHANCED CLINICAL–TRANSLATIONAL VERSION) | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF DISEASE-ORIGIN ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF VIRAGENESIS + EPIMUTAGENESIS PROGRESSION TIMELINE MAPPING TABLE | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF MULTI-NEUROSYSTEMS MAPPING ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF NEUROTRAUMA & NEUROVASCULAR TIMING ATLAS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

SCF PATHOGENESIS — GRAN MAL SEIZURES (GENERALIZED TONIC-CLONIC EPILEPSY)

SCF ADVANCED MEDICINE CLINIC — R&D PROGRAM INITIATION

SCF-PCR BRAID™ THERAPEUTIC SYSTEM | Naviquel-7 Program — Anti-Traumatic Gran Mal Seizures (GTCS)

Framework Code: SCF-PFP-N6K7-EPI-GMS-0001

Classification: SCF Product Architecture (API → Reformulation → PCR Braid Integration)

Product Architecture

From Precision APIs to Functional Cure Systems

SCF delivers a multi-layer therapeutic architecture that integrates:

Targeted APIs (Naviquel-7)
Pharmacokinetic-optimized reformulations
SCF-PCR BRAID™ systems (multi-phase seizure control)

Type	Description	Value	Regulatory Path
APIs	Precision-designed molecules targeting Nav1.6 + Kv7	Mechanistic specificity, reduced off-target effects	505(b)(1) / IND
Reformulated APIs	PK/PD optimized delivery systems (oral MR, intranasal rescue)	Improved CNS exposure, rapid onset + stability	505(b)(2)
SCF-PCR BRAID™ Therapies	Multi-layer therapeutic systems integrating FDA-approved drugs + Naviquel-7	Full-cycle seizure control (preventative, curative, restorative)	Combination product pathway

Naviquel-7 — Dual Ion-Channel Precision API

Molecular Design

Selective Nav1.6 inhibition (persistent/resurgent current)
Kv7.2/7.3 activation (M-current stabilization)
State-dependent binding → targets hyperactive neurons

Primary Targets

Target	Function	Outcome
Nav1.6 (SCN8A)	Sodium influx	↓ pathological firing
Kv7.2/7.3 (KCNQ)	Potassium efflux	↑ membrane stability

SCF Value

Precision excitability control
Reduced sedation vs broad ASMs
Foundation layer for PCR Braid integration

PK/PD-Optimized Delivery Systems

Formulation Types

Format	Function	Clinical Role
Modified-release oral	Sustained CNS exposure	Preventative baseline
Intranasal rapid delivery	Fast BBB penetration	Acute seizure rescue
Closed-loop compatible systems	Triggered dosing	Real-time intervention

Active–Excipient Engineering

CNS-targeted lipophilicity tuning
Reduced peak-to-trough variability
Controlled release aligned to seizure cycles

SCF Value

Converts molecular potency → clinical reliability
Enables time-domain precision (pre-ictal vs ictal)
Integrates with EEG-triggered delivery systems

Multi-Phase Therapeutic Architecture

Layer 1 — PREVENTATIVE (Pre-Ictal Stabilization)

Mechanism Stack

Kv7 activation → Ezogabine / XEN1101
Slow Na⁺ stabilization → Lacosamide
Redox stabilization → NAC + CoQ10

Outcome

Increased seizure threshold
Stabilized membrane potential
Suppressed pre-ictal ion drift

Layer 2 — CURATIVE (Ictal Termination)

Mechanism Stack

Fast Na⁺ blockade → Phenytoin
GABA potentiation → Diazepam / Midazolam
Synaptic suppression → Levetiracetam
Ca²⁺ suppression → Ethosuximide / Zonisamide

Outcome

Rapid seizure termination
Collapse of synchronized firing
Prevention of propagation

Layer 3 — RESTORATIVE (Postictal Realignment)

Mechanism Stack

Mitochondrial recovery → CoQ10 + Creatine
Neuroinflammation control → Anakinra
Synaptic reset → Memantine
GABA rebalancing → Valproate

Outcome

Faster cognitive recovery
Reduced neuroinflammation
Prevention of epileptogenesis

SCF-PCR BRAID™ — Synergy Engine

1+1⇒3 Functional Integration

Interaction	Result
Nav1.6 ↓ + Kv7 ↑	Membrane stabilization
Na⁺ ↓ + Ca²⁺ ↓	Seizure collapse
Ion control + Synaptic modulation	Network desynchronization
Metabolic + Ion recovery	Neuro-cognitive restoration

Emergent Effect

Full-cycle seizure control: prevention → interruption → recovery

Integration Diagram — System Flow

Naviquel-7 API
        ↓
PK/PD Reformulation Layer
        ↓
SCF-PCR BRAID™ SYSTEM

[Preventative] → [Curative] → [Restorative]

Ion Control → Network Stabilization → Cognitive Recovery

Clinical Value Proposition

Compared to Standard Anti-Seizure Therapy

Feature	Conventional ASMs	SCF-PCR BRAID™
Mechanism	Single-target	Multi-layer integrated
Timing	Static dosing	Phase-specific
Recovery	Limited	Active restoration
Precision	Low	High (state-dependent)